Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL

Clinical trial NCT03016871 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT03016871

Sponsor

City of Hope Medical Center

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-04-24

Primary completion

2024-01-30

Enrollment

78

View on ClinicalTrials.gov